Avid Bioservices Inc (CDMO)

[biopharm]

CJ, I am very impressed after reading your post with corrections from the latest conference call! I would recommend that anyone holding shares in Peregrine Pharmaceuticals to read it and anyone interested in Immunotherapy / Peregrine to certainly do your due diligence and review it thoroughly.

There are too many things to point out but I will start with the impression that some may have gotten with the stopping of Sunrise thinking it was a negative event ....we know clearly see why, in that biomarker analysis was built into Sunrise Phase III and CEO Steve King said the Bavi arm "Performed as expected" and now, more importantly we see that the information extracted from this study has been granted "late breaking" status for an oral presentation regarding the Sunrise study.

From becoming a profitable biotech company, with Peregrine owning their own successful manufacturing company (which was the driver behind preceded share offerings selling at future prices and....here is the part I really like ==> the part where some may have thought Peregrine was selling the ATM and

All must read the transcript to realize there was no selling related to the ATM which means some big buyers KNOW the scale of biotech and IO and KNOW Peregrine is about to tilt that scale.

Much more but I suggest read the transcript 2-3 times and come to realize the events that are happening Soon...

A big thanks CJ!

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=125071406